Ironwood Pharmaceuticals | Koszty Sprzedaży



Cost Of Sales Zmiana Data
Acadia Pharmaceuticals USD 20.39M 1.41M 2025-03
Agios Pharmaceuticals USD 1.08M 175K 2025-03
Almirall EUR 111.11M 94.38M 2024-12
Alnylam Pharmaceuticals USD 71.04M 31.78M 2025-03
Amarin USD 26.02M 1.3M 2024-09
Ardelyx USD 18.26M 2.54M 2024-12
Astellas Pharma JPY 76.86B 21.67B 2025-03
AstraZeneca USD 2.24B 484M 2025-03
Charles River Laboratories USD 666.44M 16.43M 2025-03
Exact Sciences USD 206.24M 77.89M 2025-03
Halozyme Therapeutics USD 48.4M 6.35M 2025-03
Incyte USD 67.8M 14.58M 2025-03
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
MacroGenics USD 5.49M 3.62M 2024-12
Moderna USD 90M 456M 2025-03
Myriad Genetics USD 61.7M 2M 2025-03
Pacira USD 34.31M 5.58M 2025-03
PTC Therapeutics USD 12.86M 3.42M 2025-03
Sarepta Therapeutics USD 137.56M 5.26M 2025-03
Takeda JPY 382.08B 34.8B 2025-03
Ultragenyx Pharmaceutical USD 28.66M 11.77M 2025-03



Ironwood Pharmaceuticals Koszty Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.